EMA — authorised 31 December 2009
- Application: EMEA/H/C/001221
- Marketing authorisation holder: Janssen-Cilag International NV
- Local brand name: Comfyde
- Status: withdrawn
🇪🇺 CARISBAMATE in European Union
EMA authorised CARISBAMATE on 31 December 2009
Marketing authorisation
Other Neuroscience approved in European Union
Frequently asked questions
Is CARISBAMATE approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for CARISBAMATE in European Union?
Janssen-Cilag International NV holds the EU marketing authorisation.